Brought to you by 
Theraclion and Furui create joint venture to market Echopulse in China
25 Apr 2017
Executive Summary
Theraclion SAS and Inner Mongolia Furui Medical Science Co. Ltd. agreed to create a joint venture named Theraclion China Co. Ltd. to market Theraclion’s Echopulse therapeutic ultrasound device in China.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Theraclion and Furui create joint venture to market Echopulse in China
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice